October 04, 2023 — Copenhagen, Denmark — With this collaboration, Radiobotics and ImageBiopsy Lab aim to target the DACH region and offer a single, comprehensive solution for MSK imaging, encompassing measurement, scoring, and fracture detection workflows, thereby providing the most comprehensive software package available.
To date, both companies are offering their AI-based platforms as individual solutions for standardised, effective, and precise diagnosis of chronic and traumatic MSK conditions, offering a range of modules that are optimised for specific bone systems of the body such as knee, hip, hand, spine and more.
Despite a growing number of MSK-specific solutions, end-users lack a complete, one-stop-shop solution for addressing the multitude of diagnostic use cases. Often, existing solutions do not adequately address the specific needs of radiologists, orthopaedic-and trauma surgeons. To close this diagnostic gap, the two leading AI companies in that space have agreed to combine their expertise and market knowledge in order to offer a complete and comprehensive solution.
Dr. Richard Ljuhar, CEO and Co-Founder of ImageBiopsy Lab:
“Understanding the diagnostic workflow and needs of physicians are the key elements before even starting to think of the use of AI. For years now, we have been working closely with leading MSK radiologists, orthopaedics and traumatologists to not just understand how AI can play a role in MSK diagnostics, but also to discover how solutions can be seamlessly integrated into existing workflows. We have made it our vision to transform the entire diagnostic MSK value chain for the benefit of practitioners, patients and the overall healthcare system. We see Radiobotics as the logical partner to offer best in class solutions for MSK conditions diagnostics, from measurements and scoring to fracture detection. Such collaborations are the next step in the evolution of AI-powered workflow integrations and we are excited to partner with Radiobotics on this journey.”
Mads Jarner, CEO and Co-Founder of Radiobotics:
“As we acknowledge growing field and interest in adopting MSK AI-solutions into the clinical workflow, we see a clear advantage for clinics to get access to combined and more comprehensive solutions, why we are really happy to be able to work with ImageBiopsy Lab, ensuring that customers can leverage getting easier access to the market leading solutions that we’ve both built. With ImageBiopsy Labs’ expertise and deep network in the German speaking regions, we are excited to be able to offer our fracture detection solution RBfracture™ in this region initially, and hope to be able to expand into other areas.”
About ImageBiopsy Lab:
ImageBiopsy Lab’s mission is to improve the quality of life of more than a billion patients suffering from musculoskeletal (MSK) diseases by providing AI-driven imaging intelligence that optimizes the medical workflows enabling early detection and prevention of MSK diseases.
Founded in 2016, ImageBiopsy Lab has become the leading musculoskeletal (MSK) AI-supported imaging intelligence company. We are at the forefront of healthcare’s transformational shift and have grown into a successful global scale-up with customers and partners all over the world. Innovation is an integral part of the company’s continuous evolution.
About Radiobotics:
Founded in 2017, Radiobotics is an award-winning MedTech company dedicated to advancing musculoskeletal (MSK) radiology with AI-powered solutions. Radiobotics’ flagship solution, RBfracture™, is designed to support Emergency and Radiology with highly accurate detection of trauma-related findings, including fractures, dislocations, lipohemarthrosis, and effusions.
Radiobotics’ commitment to delivering precise, expert-level care in MSK imaging 24/7, regardless of time, infrastructure, or staffing constraints, has been recognized in the industry with numerous accolades, including Best New Radiology Vendor at the EuroMinnies 2022, a nomination for Digital Europe’s Future Unicorn Award in 2021, and a 2020 EIC Accelerator grant.
